Splash Beverage Group Submits NYSE Compliance Plan; Medterra LOI Expired
Splash Beverage Group provided a corporate update on its NYSE American compliance process and strategic transaction initiatives. The company submitted its compliance plan to NYSE American on May 28, 2026, following a notice of non-compliance with listing standards related to stockholders' equity, with a potential cure period extending through January 29, 2027. Additionally, the non-binding Letter of Intent with Medterra CBD, LLC expired on May 4, 2026, without a definitive agreement, though Splash is actively evaluating new strategic opportunities in the cannabinoid wellness sector and is in preliminary negotiations with multiple potential counterparties. The company also disclosed that its 2025 Annual Report included an audit opinion with an explanatory paragraph regarding its ability to continue as a going concern.
Key Highlights
- NYSE American non-compliance notice received on April 29, 2026.
- Compliance plan submitted to NYSE American on May 28, 2026.
- Potential cure period for NYSE compliance could extend through January 29, 2027.
- Non-binding LOI with Medterra CBD, LLC expired on May 4, 2026.
- Company is actively evaluating new strategic opportunities in cannabinoid wellness.
- 2025 Annual Report on Form 10-K included a going concern audit opinion.
Price Impact
More from SBEV